Conference Presentation, Panel
Things That Will Blow Your Mind | Milken Institute Global Conference 2024
- Four concepts are projected to evolve into food derived from air, advanced brain-computer interfaces (BCI), hybrid cognitive AI, and next-generation genetic engineering capable of curing previously incurable diseases.
- BCI technology is expected to enable a user to verbally think content that is transcribed with higher accuracy than manual output within approximately two years, following a progression from funding to human implantation in just over two years.
- Current BCI implementation has reached 14 implants with an insertion rate of nearly one per week, with expectations to eventually impact millions of patients by restoring digital control superior to able-bodied capabilities.
- Future BCI interfaces are anticipated to become more seamless and intuitive, paralleling the historical shift from punch cards to mice and keyboards, while large-scale capital availability is expected to drive software-led real-world applications.
- Large language models are predicted to be superseded by precision platforms capable of translating natural language specifications into runtime applications that dialogue without hallucination, optimizing for variables like price and distance while explaining trade-offs.
- New AI systems are forecast to automate general enterprise problem-solving for complex issues with guaranteed accuracy, though the speaker remains optimistic while urging deep management of such technologies.
- Food production technology aims to create closed-loop carbon cycles to generate protein ingredients in hours, targeting economic competitiveness against traditional sources like gluten and whey while maintaining flavor neutrality.
- The broader food industry is expected to address the nutritional needs of a growing population reaching 9 to 10 billion over the next 20 to 30 years without exceeding planetary limits, potentially achieving 30 to 40 net-zero progress by 2030 and 2040 respectively.
- Prime Editing is expected to cure rather than treat diseases, including common and rare genetic disorders, by correcting any gene in any cell, with the first IND for chronic granulomatous disease recently approved to initiate trials.
- Clinical data serving as a proof of concept for human prime editing is expected to be reported by this time next year, with the technology anticipated to dramatically extend lifespans and eliminate disease.
- While recognizing that scientific advances carry potential risks, the outlook emphasizes a collective responsibility to ensure these technologies improve the planet and human lives, with expectations that the human race will evolve psychologically alongside accelerating technological capabilities.